Skip to main content
Clinical Trials/CTRI/2024/05/067399
CTRI/2024/05/067399
Not yet recruiting
Phase 3

Intrathecal hyperbaric bupivacaine versus hyperbaric ropivacaine in spinal anaesthesia in caesarean sections: a randomised control trial in a teaching hospital in northeast India. - Nil

eon0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
eon
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
eon

Eligibility Criteria

Inclusion Criteria

  • i.All patients who will be registered for elective caesarean delivery and belonging to ASA (American Society of Anesthesiologists) grade I \& II only.
  • ii.Patients between 145to 165 cms of height.
  • iii.Patients who will give valid informed written consent.
  • iv.Pregnancy over 37 weeks and less than 42 weeks.
  • v.Patient with weight of 45\-95kgs.
  • vi.Patients with age between 18years and 40 years.

Exclusion Criteria

  • i.Patient with abnormalities and problems in the embryo.
  • ii.Patient with indication of an emergency caesarean section.
  • iii.Patients having history of hypersensitivity to anesthetic agents.
  • iv.Infection at the subarachnoid block injection site.
  • v.Pre\-term and post term delivery.
  • vi.ASA class higher than II.

Outcomes

Primary Outcomes

Not specified

Similar Trials